Comparison of several combinations maintenance and reliever therapy for asthma patients
Background: If asthma patients fail to achieve symptom control using a medium dose of inhaled corticosteroid (ICS) alone, addition of a long-acting β2 agonist (LABA) is the preferred treatment. Currently, there are several combinations of ICS/LABA that are available. Objective: Compare the effects...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2018-06-01
|
| Series: | Revista Alergia México |
| Subjects: | |
| Online Access: | http://revistaalergia.mx/ojs/index.php/ram/article/view/423 |